Matt Schwartz @matt_is_nice

CEO & co-founder of Virgo. Building AI to better detect cancers and predict other diseases from routine endoscopy. Side projects: @endoML_ai and @BenGPThompson virgosvs.com Carlsbad, CA Joined April 2014

Tweets

5K
Followers

1K
Following

2K
Likes

16K

Matt Schwartz @matt_is_nice

11 hours ago

We've built an endoscopy encoder model trained on 130,000 HD procedure videos. Encoder models enable predictive risk scores for Ulcerative Colitis and Crohn's Disease from baseline colonoscopies

0 1 3 119 0

Ron Alfa @ron_alfa

a day ago

We don’t need to simulate the subcellular physico-chemical properties of cells. We need to model biology that will help us cure disease in patients. That means cell biology in the context of tissues and patients.

11 7 109 10K 26

Matt Schwartz @matt_is_nice

a day ago

Placebo variance is killing IBD trials. EndoDINO forecasts placebo response from baseline colonoscopy. This means smaller, faster trials. And few patients getting placebo!

0 1 1 86 0

Matt Schwartz @matt_is_nice

2 days ago

One idea for improving drug development in IBD (ulcerative colitis and Crohn's disease) is to improve the outcome measures. AI encoder models can pull predictive biomarkers from baseline colonoscopies creating more meaningful outcome measures.

0 0 0 78 0

Matt Schwartz @matt_is_nice

2 days ago

In 2017 Virgo filed a patent for automating medical note generation with AI synthesis of text, audio, and video data. AI scribes are taking off in the clinic, and we see tons of potential to do the same for procedures. Our EndoDINO foundation model makes this a possibility.

0 2 3 192 0

Download Image

Steve Hou @stevehou0

2 days ago

What if, now hear me out, what if the tariffs are destroying the economy?

1K 1K 18K 734K 199

Matt Schwartz @matt_is_nice

2 days ago

There are over 25 million GI endoscopies done every year in the US... One of the best ways to improve surgical outcomes is to prevent the need for surgery in the first place! Tons of opportunity to leverage predictive AI to avoid patients needing surgery.

0 0 2 258 0

Propel a Cure for Crohn’s Disease @propelacure

2 weeks ago

“Why do we need new targets for Crohn’s therapies?“ In this 1 Minute Inside IBD, the Promakhos Therapeutics team explains: ✨ Current drugs have hit their ceiling of efficacy ✨ There’s an upstream problem driving disease ✨ The real goal is restoring the innate immune system…

3 6 29 2K 5

Download Video

Propel a Cure for Crohn’s Disease @propelacure

3 days ago

@matt_is_nice Matt, here are several groundbreaking #IBD studies we are currently sponsoring, along with the latest updates: propelacure.org/researchprojec…

1 1 4 137 0

Matt Schwartz @matt_is_nice

3 days ago

IBD needs biomarkers that are good enough to run biomarker-defined population trials like in oncology. AI endoscopic biomarkers most promising path IMO. Will be a major shift from all-comer drugs we have today, but this is the path to real improvements.

0 0 2 62 0

Matt Schwartz @matt_is_nice

3 days ago

Steve gave a talk on Deep Learning ~2015/2016 that inspired me to take machine learning courses and ultimately found Virgo. Can blindly recommend checking this out!

Steve Jurvetson @FutureJurvetson

3 days ago

Steve gave a talk on Deep Learning ~2015/2016 that inspired me to take machine learning courses and ultimately found Virgo. Can blindly recommend checking this out!